BAC
Bank of America Corporation
BAC offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BAM
Brookfield Asset Management Ltd.
BAM has the edge over BAC overall, supported by stronger valuation and stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BAM Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
BAM's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAM.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over BAM in the historical PE scenario, which offers more potential upside but is not a forecast.
BAM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $51.41 | — |
| Forward | 25x | $51.41 | — |
| Cheap | 35x | $104 | +101% |
| Fair | 45x | $132 | +157% |
| Expensive | 53x | $154 | +200% |
Historical ranges are pointers, not guarantees.
BAM's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 25x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over BAM on the outlook, with more favorable valuation and profitability expectations.
BAM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAM, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over BAM on earnings, with stronger typical year-over-year growth.
BAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.05 | -30% |
| Q3 2026 | $2.92 | +83% |
| Q2 2026 | $1.72 | +15% |
| Q1 2026 | $1.54 | +7.7% |
| Q4 2025 | $1.52 | +13% |
| Q2 2025 | $1.50 | +33% |
| Q4 2024 | $1.35 | +19% |
| Q2 2024 | $1.13 | +77% |
| Q4 2023 | $1.13 | -62% |
BAM earned $2.92 per share over the past year, up 83% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
BAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.1B | +89% |
| Q2 2026 | $1.7B | +57% |
| Q1 2026 | $1.3B | +22% |
| Q4 2025 | $1.2B | +16% |
| Q3 2025 | $1.1B | +2.1% |
| Q2 2025 | $1.1B | +19% |
| Q1 2025 | $1.1B | +22% |
| Q2 2022 | $924M | +25% |
BAM has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 57% | -9.5 points |
| Q2 2026 | 54% | -7.3 points |
| Q1 2026 | 49% | -27 points |
| Q4 2025 | 77% | +4.7 points |
| Q3 2025 | 67% | -2.1 points |
| Q2 2025 | 61% | -7.1 points |
| Q1 2025 | 75% | +7.6 points |
| Q4 2024 | 72% | N/A |
BAM has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
BAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $521M | -30% |
| Q2 2026 | $392.8M | -26% |
| Q1 2026 | $339M | +28% |
| Q4 2025 | $706M | +$1.6B |
| Q3 2025 | $741M | +31% |
| Q2 2025 | $529M | +35% |
| Q1 2025 | $265M | -48% |
| Q2 2022 | $2.7B | +31% |
BAM's free cash flow was $2B over the past year, up 186% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAM.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BAM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BAM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -21.4M shares |
| 1 year | -2.9% | -47.6M shares |
| 3 years | +300% | +1.2B shares |
BAM has 1.6B diluted shares, down 2.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10M |
| Q2 2026 | $103M |
| Q1 2026 | $376M |
| Q4 2025 | $227M |
| Q3 2025 | $69M |
| Q2 2025 | — |
| Q1 2025 | $116M |
| Q4 2024 | — |
BAM spent $716M buying back its own shares over the past year, about four times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BAM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.1x | Very low |
BAM has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.6 | Neutral |
| Stochastic | 58.7 | Neutral |
BAM's weekly RSI is 57 (neutral) and its Stochastic is 59 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over BAM on valuation relative to its sector.
BAM PE vs Financial Services Sector
| Metric | BAM | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 35% above |
| PE % | 10 | 54 | 44 pts below |
BAM is trading at 18x earnings, a 35% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.5 | 8.1% above |
| 20 week MA | $48.6 | 5.9% above |
| 50 week MA | $48.7 | 5.6% above |
| 100 week MA | $52.1 | 1.2% below |
| 200 week MA | $45.2 | 14% above |
BAM has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
BAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $33.0 | $28.0 | -15% |
| 2023 | $28.0 | $40.2 | +43% |
| 2024 | $40.2 | $54.6 | +36% |
| 2025 | $54.6 | $53.4 | -2.3% |
| 2026 YTD | $53.4 | $51.4 | -3.7% |
BAM has the edge over BAC on returns for 2026, with the stronger performance.